ES2057731T3 - Preparaciones que contienen gonadotropinas estabilizadas. - Google Patents

Preparaciones que contienen gonadotropinas estabilizadas.

Info

Publication number
ES2057731T3
ES2057731T3 ES91200483T ES91200483T ES2057731T3 ES 2057731 T3 ES2057731 T3 ES 2057731T3 ES 91200483 T ES91200483 T ES 91200483T ES 91200483 T ES91200483 T ES 91200483T ES 2057731 T3 ES2057731 T3 ES 2057731T3
Authority
ES
Spain
Prior art keywords
preparations
lyophilized
dicarboxylic acid
disclosed
acid salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91200483T
Other languages
English (en)
Inventor
Andreas Leo Johannes De Meere
Marinus Arie De Ruiter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2057731T3 publication Critical patent/ES2057731T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE EXPONEN PREPARADOS QUE CONTIENEN GONADATROPINA LIOFILIZADA QUE CONTIENEN UN ESTABILIZADOR DE UNA SAL DE ACIDO DICARBOXILICO. LAS PROTEINAS INDIVIDUALES (POR EJEMPLO, LH, TSH, FSH, O HCG) ESTAN MEZCLADAS CON EL ESTABILIZADOR EN FORMA LIOFILIZADA, Y SON CAPACES, AL MENOS PARCIALMENTE, DE ESTABILIZACION MEDIANTE DICHO ESTABILIZADOR. LOS PREPARADOS CONTIENEN UNA CANTIDAD SUFICIENTE DE SAL DE ACIDO DICARBOXILICO COMO PARA ESTABILIZAR LA PROTEINA EN UNA FORMA CONGELADA-DESECADA DURANTE EL TIEMPO DESEADO A LA TEMPERATURA DESEADA. LAS TIPICAS SALES DE ACIDO DICARBOXILICO EXPUESTAS SON LAS SALES DE LOS ACIDOS CITRICO, TARTARICO Y ASPARTICO. LOS PREPARADOS INCLUYEN PREFERENTEMENTE UN DISACARIDO NO REDUCTOR PARA AUMENTAR LA TEMPERATURA DE COLAPSO DE LA SOLUCION QUE SE HA DE LIOFILIZAR. SE EXPONEN TAMBIEN METODOS DE FABRICACION DE LOS PREPARADOS EN FORMA LIOFILIZADA Y LOS PREPARADOS INYECTABLES RESULTANTES.
ES91200483T 1990-03-20 1991-03-06 Preparaciones que contienen gonadotropinas estabilizadas. Expired - Lifetime ES2057731T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90200665 1990-03-20

Publications (1)

Publication Number Publication Date
ES2057731T3 true ES2057731T3 (es) 1994-10-16

Family

ID=8204967

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91200483T Expired - Lifetime ES2057731T3 (es) 1990-03-20 1991-03-06 Preparaciones que contienen gonadotropinas estabilizadas.

Country Status (16)

Country Link
EP (1) EP0448146B1 (es)
JP (1) JP3031570B2 (es)
KR (1) KR100221123B1 (es)
AT (1) ATE107172T1 (es)
AU (1) AU631730B2 (es)
CA (1) CA2037884C (es)
DE (1) DE69102465T2 (es)
DK (1) DK0448146T3 (es)
ES (1) ES2057731T3 (es)
FI (1) FI101194B (es)
HK (1) HK1002494A1 (es)
ID (1) ID905B (es)
IE (1) IE64738B1 (es)
NZ (1) NZ237458A (es)
PT (1) PT97074B (es)
ZA (1) ZA911659B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
KR100334856B1 (ko) * 1993-04-28 2002-11-07 악조 노벨 엔.브이. 성선자극호르몬을포함하는냉동건조구
JP4165878B2 (ja) * 1993-06-03 2008-10-15 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
US5556771A (en) * 1995-02-10 1996-09-17 Gen-Probe Incorporated Stabilized compositions of reverse transcriptase and RNA polymerase for nucleic acid amplification
PT814841E (pt) 1995-03-21 2002-03-28 Applied Research Systems Formulacoes liquidas de hcg
IL120202A (en) 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
WO2000004913A1 (en) * 1998-07-23 2000-02-03 Eli Lilly And Company Fsh and fsh variant formulations, products and methods
CA2369262A1 (en) 1999-04-13 2000-10-19 Sudha Nagarajan Pulmonary administration of dry powder formulations for treating infertility
SK286421B6 (sk) * 2000-10-31 2008-09-05 Pharma Mar, S. A. Prostriedok kahalalid F, súprava, rekonštituovanýa zriedený roztok s obsahom tohto prostriedku a použitie
EP1356809A4 (en) 2000-12-28 2008-05-14 Takeda Pharmaceutical SUSTAINED RELEASE PREPARATIONS
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
KR101105486B1 (ko) * 2003-04-02 2012-01-13 아레스 트레이딩 에스.에이. Ｆｓｈ 및 ｌｈ과 비이온성 계면활성제의 액상 약제학적 제제
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
ES2414705T3 (es) 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
DE10333317A1 (de) * 2003-07-22 2005-02-17 Biotecon Therapeutics Gmbh Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
EP3167961A1 (en) 2004-04-08 2017-05-17 Biomatrica, Inc. Integration of sample storage and sample management for life science
EP1987067A4 (en) * 2006-02-15 2012-01-25 Imclone Llc ANTIBODY FORMULATION
AU2008320844B2 (en) 2007-11-01 2013-08-29 Merck Serono S.A. LH liquid formulations
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
US8519125B2 (en) 2009-05-11 2013-08-27 Biomatrica, Inc. Compositions and methods for biological sample storage
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
SG190136A1 (en) 2010-11-05 2013-07-31 Baxter Int A new variant of antihemophilic factor viii having increased specific activity
CN102293756A (zh) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 一种尿促性素冻干粉针剂及其制备方法
HUE037811T2 (hu) 2011-10-28 2018-09-28 Prothena Biosciences Ltd Alfa-szinukleint felismerõ humanizált antitestek
EP2807188B1 (en) 2012-01-27 2019-09-11 Prothena Biosciences Limited Humanized antibodies that recognize alpha-synuclein
UA118441C2 (uk) 2012-10-08 2019-01-25 Протена Біосаєнсиз Лімітед Антитіло, що розпізнає альфа-синуклеїн
EP3249054A1 (en) 2012-12-20 2017-11-29 Biomatrica, INC. Formulations and methods for stabilizing pcr reagents
US10513555B2 (en) 2013-07-04 2019-12-24 Prothena Biosciences Limited Antibody formulations and methods
EP3154338B1 (en) 2014-06-10 2020-01-29 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
WO2017100212A1 (en) 2015-12-08 2017-06-15 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
IT1057895B (it) * 1975-02-17 1982-03-30 Serono Lab Gonadotropina corionica umana parzialmente desalinizzata per indurre l'ouvulazione
ATE31023T1 (de) * 1983-04-28 1987-12-15 Armour Pharma Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.
GB8604983D0 (en) * 1986-02-28 1986-04-09 Biocompatibles Ltd Protein preservation
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration

Also Published As

Publication number Publication date
JPH04217630A (ja) 1992-08-07
ZA911659B (en) 1991-12-24
FI101194B1 (fi) 1998-05-15
DK0448146T3 (da) 1994-10-24
NZ237458A (en) 1992-02-25
FI911309A (fi) 1991-09-21
DE69102465D1 (de) 1994-07-21
ATE107172T1 (de) 1994-07-15
JP3031570B2 (ja) 2000-04-10
CA2037884C (en) 2003-10-21
PT97074B (pt) 1998-10-30
DE69102465T2 (de) 1995-03-02
KR910016340A (ko) 1991-11-05
AU631730B2 (en) 1992-12-03
EP0448146A1 (en) 1991-09-25
FI101194B (fi) 1998-05-15
ID905B (id) 1996-09-10
PT97074A (pt) 1991-10-31
IE64738B1 (en) 1995-09-06
AU7362391A (en) 1991-09-26
FI911309A0 (fi) 1991-03-18
EP0448146B1 (en) 1994-06-15
KR100221123B1 (ko) 1999-09-15
CA2037884A1 (en) 1991-09-21
HK1002494A1 (en) 1998-08-28
IE910732A1 (en) 1991-09-25

Similar Documents

Publication Publication Date Title
ES2057731T3 (es) Preparaciones que contienen gonadotropinas estabilizadas.
DE69813322T2 (de) Flüssige gonadotropinhaltige Arzneimittel
RU98100930A (ru) Жидкие композиции, содержащие гонадотропин
DE69233188D1 (de) Hormonanaloge mit mehreren ctp-erweiterungen
CA2125855A1 (en) A stabilized pharmaceutical formulation comprising growth hormone and histidine
DE69230672D1 (de) Gonadotropin, das pharmazeutische zusammensetzungen mit sucrose stabilisator enthält
KR970706841A (ko) 성장호르몬 및 루신으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and leucine)
US5384132A (en) Stabilized gonadotropin containing preparations
MX9302509A (es) Composiciones de polipeptidos estables en almacenamiento y metodo para su preparacion.
US5270057A (en) Stabilized gonadotropin containing preparations
EP0294667A3 (en) (2-cyano-2-oximinoacetyl)-amino acid derivatives
DE69217686D1 (de) Pharmazeutische Zusammensetzung von stabilisiertem [Leu 13]-Motilin-Hse
Slyvchuk et al. Stabilizing the gonadotropin activity with the use of organic compounds
DE59008754D1 (de) Verfahren zur Herstellung von granuliertem Natriumacetat-Trihydrat.
DK661888A (da) Biologisk aktive molekyler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 448146

Country of ref document: ES